You just read:

ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer's Disease

News provided by

ProMIS Neurosciences Inc.

Oct 17, 2017, 07:30 ET